PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19760669-0	2009	Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in mice.	Azoxymethane	71-83	insulin-like growth factor 1	Mus musculus	33-61	
31480481-3	2019	However, the effect of a combined treatment of microencapsulated BF and LYC on IGF-1/IGF-1R/IGFBPs (Insulin-like growth factor-binding proteins) expression in an azoxymethane (AOM)-dextran sulfate sodium (DSS)-induced CRC model have not been demonstrated.	Azoxymethane	162-174	insulin-like growth factor 1	Mus musculus	79-84	
31480481-3	2019	However, the effect of a combined treatment of microencapsulated BF and LYC on IGF-1/IGF-1R/IGFBPs (Insulin-like growth factor-binding proteins) expression in an azoxymethane (AOM)-dextran sulfate sodium (DSS)-induced CRC model have not been demonstrated.	Azoxymethane	176-179	insulin-like growth factor 1	Mus musculus	79-84	
19760669-6	2009	We conducted a pilot study to assess the impact of liver-specific IGF-1 deficiency on azoxymethane (AOM)-induced colon tumors.	Azoxymethane	86-98	insulin-like growth factor 1	Mus musculus	66-71	
19760669-6	2009	We conducted a pilot study to assess the impact of liver-specific IGF-1 deficiency on azoxymethane (AOM)-induced colon tumors.	Azoxymethane	100-103	insulin-like growth factor 1	Mus musculus	66-71